Page 14 - Sanket Koul

PM Modi asks scientists to focus on R&D, secure patents for new drugs

PM says move will ensure self-reliance in the pharmaceuticals segment

Realty, hospitality firms upbeat on GST Diwali bonanza and tax relief

Real estate and hospitality companies hope that GST reforms, including lower taxes and simplified compliance, will boost demand, support tourism, and aid in the growth of the economy

NHA, C-DAC launch e-Sushrut@Clinic HMIS for small healthcare providers

NHA and C-DAC have launched e-Sushrut@Clinic, a lightweight, ABDM-enabled HMIS for small and medium healthcare providers to digitise records and offer telemedicine at low cost

Housing micro markets delivering gains for homeowners, investors: Anarock

Delhi NCR's Noida Sector 150 micro market led the pack with a 139 per cent growth in capital values at Rs 13,600 per square feet in Q2 2025 compared to Rs 5,700 per square feet at the end of 2021

Alkem Labs Q1 profit rises 22% to ₹664 cr on India, overseas sales growth

Alkem Labs Q1FY26 profit rose 22% YoY to ₹664.3 crore, with strong growth in India and international sales; company to boost focus on high-potential non-US markets

Zydus Lifesciences Q1 PAT up 5.9% on strong India, int'l formulations biz

The growth was driven by strong performances in the company's domestic and international formulations segments, even as its consumer wellness and US businesses saw muted growth

GIC, TPG-backed AHH targets 20 AINU hospitals by FY30, eyes GI entry

AHH aims for 20 nephrology and urology hospitals under AINU by FY30, plans GI expansion, and leaves IPO timing to investor decision despite readiness within 18 months

Poly Medicure to invest ₹500 cr in new plants for global market push

However, this foreign push comes at a time when the device maker is seeing headwinds arising out of short-term demand uncertainties due to on-going geopolitical tensions and tariff issues

Signature Global to launch ₹14,000 crore projects by festive season

Realty firm plans launches in Dwarka Expressway and SPR; Q1 net profit up 386% to ₹34 crore, revenue doubles on project completions and strong sales realisation

Medical devices industry raises concerns over additional 25% US tariff

With US duties on Indian medical devices now at 50%, industry groups warn of trade instability, lost competitiveness, and adverse impact on American patients

Indian pharma market grows 7.9% in July, led by chronic therapies

Despite flat volumes, India's pharma market posted 7.9% growth in July on strong demand for chronic therapies like cardiac and diabetes; MAT turnover crossed Rs 2.3 trillion

Haryana hospitals to continue AB-PMJAY strike despite partial payments

IMA Haryana says hospitals will continue Ayushman Bharat services suspension over Rs 500 crore dues, citing trust deficit with state health agency despite partial repayments

Fortis Q1 profit jumps 53% to ₹267 cr, revenue up 16.6% on strong growth

Fortis Healthcare Q1FY26 profit rises 53% to ₹266.78 crore as hospital and diagnostics businesses drive 16.6% revenue growth and Ebitda margin improves to 22.6%

Eris Lifesciences to target insulin, semaglutide mkt opportunities in FY26

Eris Lifesciences to leverage Novo Nordisk's exit and semaglutide patent expiry, with cartridge capacity and diabetes-focused products planned for commercialisation in FY26

Realty major DLF targets luxury segment launches in the near term

DLF plans ultra-premium launches in FY27, including Golf Course Extension; rental income from Downtown Gurugram and Atrium Place to begin by end-2025

All Kartavya Bhavans may be ready in 2 years: Manohar Lal Khattar

PM Modi to inaugurate the first Common Central Secretariat building, Kartavya Bhavan, on Wednesday as part of the Central Vista plan; others to be ready by 2026

Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue

Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT due to lower API sales and US market revenue, while its European and growth markets continue to show positive momentum

DLF Q1 FY26 results: PAT up 18% on record sales of over ₹11,425 crore

Revenue nearly doubles to Rs 2,716 crore in Q1 FY26, as DLF meets strong demand for luxury homes and continues expansion in Mumbai, Goa, and Gurugram

Delhi NCR-based Nimbus Group to invest ₹1,100 cr in stalled luxury project

Nimbus Group will invest Rs 1,100 crore to revive the stalled Arista Luxe Phase II project in Noida, aiming for completion by 2029 and offering luxury apartments priced between Rs 4-6 crore

DRL to Cipla: Pharma Inc firms up plans to launch anti-obesity drugs

Push comes as patents are set to expire in March 2026